nodes	percent_of_prediction	percent_of_DWPC	metapath
Bretylium—ATP1A1—Preimplantation Embryo—SOX11—hematologic cancer	0.00995	0.0871	CbGpPWpGaD
Bretylium—ATP1A1—Ion transport by P-type ATPases—FXYD6—hematologic cancer	0.00958	0.0839	CbGpPWpGaD
Bretylium—ATP1A1—Preimplantation Embryo—AQP9—hematologic cancer	0.00811	0.071	CbGpPWpGaD
Bretylium—ATP1A1—Preimplantation Embryo—PBX1—hematologic cancer	0.00811	0.071	CbGpPWpGaD
Bretylium—ATP1A1—Ion transport by P-type ATPases—ATP1B1—hematologic cancer	0.00683	0.0598	CbGpPWpGaD
Bretylium—ATP1A1—Ion transport by P-type ATPases—ATP4A—hematologic cancer	0.00592	0.0518	CbGpPWpGaD
Bretylium—ATP1A1—Preimplantation Embryo—GATA2—hematologic cancer	0.00592	0.0518	CbGpPWpGaD
Bretylium—ATP1A1—Preimplantation Embryo—IRF4—hematologic cancer	0.00572	0.0501	CbGpPWpGaD
Bretylium—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC22A1—hematologic cancer	0.00356	0.0312	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—FXYD6—hematologic cancer	0.00332	0.029	CbGpPWpGaD
Bretylium—ATP1A1—Preimplantation Embryo—SMARCA4—hematologic cancer	0.00293	0.0256	CbGpPWpGaD
Bretylium—ATP1A1—Preimplantation Embryo—GATA3—hematologic cancer	0.00262	0.023	CbGpPWpGaD
Bretylium—SLC6A2—Amine compound SLC transporters—SLC22A1—hematologic cancer	0.00247	0.0216	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—ATP1B1—hematologic cancer	0.00236	0.0207	CbGpPWpGaD
Bretylium—SLC6A2—Monoamine Transport—TNFRSF11B—hematologic cancer	0.00229	0.02	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—SGK1—hematologic cancer	0.00205	0.0179	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—ATP4A—hematologic cancer	0.00205	0.0179	CbGpPWpGaD
Bretylium—ATP1A1—hematopoietic system—hematologic cancer	0.00134	0.151	CbGeAlD
Bretylium—ATP1A1—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.00124	0.0109	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.00115	0.0101	CbGpPWpGaD
Bretylium—SLC6A2—Monoamine Transport—TSC2—hematologic cancer	0.00106	0.00932	CbGpPWpGaD
Bretylium—ATP1A1—gonad—hematologic cancer	0.00102	0.115	CbGeAlD
Bretylium—SLC6A2—Monoamine Transport—MAPK14—hematologic cancer	0.00101	0.00888	CbGpPWpGaD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—hematologic cancer	0.000966	0.00846	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000941	0.00824	CbGpPWpGaD
Bretylium—SLC6A2—gonad—hematologic cancer	0.000906	0.102	CbGeAlD
Bretylium—ATP1A1—blood—hematologic cancer	0.000889	0.1	CbGeAlD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000875	0.00766	CbGpPWpGaD
Bretylium—ATP1A1—bone marrow—hematologic cancer	0.00086	0.0968	CbGeAlD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000822	0.0072	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.00078	0.00683	CbGpPWpGaD
Bretylium—ATP1A1—lung—hematologic cancer	0.000779	0.0877	CbGeAlD
Bretylium—SLC6A2—NRF2 pathway—ABCC3—hematologic cancer	0.000761	0.00667	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—TXN—hematologic cancer	0.000761	0.00667	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000745	0.00652	CbGpPWpGaD
Bretylium—ATP1A1—testis—hematologic cancer	0.000735	0.0828	CbGeAlD
Bretylium—Diarrhoea—Melphalan—hematologic cancer	0.00073	0.000832	CcSEcCtD
Bretylium—Gastrointestinal pain—Thiotepa—hematologic cancer	0.000728	0.00083	CcSEcCtD
Bretylium—Nausea—Chlorambucil—hematologic cancer	0.000727	0.000829	CcSEcCtD
Bretylium—Anxiety—Cisplatin—hematologic cancer	0.000725	0.000827	CcSEcCtD
Bretylium—Hyperhidrosis—Gemcitabine—hematologic cancer	0.000724	0.000825	CcSEcCtD
Bretylium—Dyspnoea—Ifosfamide—hematologic cancer	0.000722	0.000823	CcSEcCtD
Bretylium—Affect lability—Epirubicin—hematologic cancer	0.000718	0.000818	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—UGT1A1—hematologic cancer	0.000716	0.00627	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000713	0.00624	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000713	0.00624	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000713	0.00624	CbGpPWpGaD
Bretylium—Vomiting—Vinblastine—hematologic cancer	0.000713	0.000813	CcSEcCtD
Bretylium—Nausea—Nilotinib—hematologic cancer	0.000711	0.000811	CcSEcCtD
Bretylium—Diarrhoea—Lenalidomide—hematologic cancer	0.00071	0.000809	CcSEcCtD
Bretylium—Feeling abnormal—Thalidomide—hematologic cancer	0.000709	0.000809	CcSEcCtD
Bretylium—Nausea—Imatinib—hematologic cancer	0.000707	0.000806	CcSEcCtD
Bretylium—Gastrointestinal pain—Thalidomide—hematologic cancer	0.000704	0.000803	CcSEcCtD
Bretylium—Vertigo—Etoposide—hematologic cancer	0.000704	0.000803	CcSEcCtD
Bretylium—Body temperature increased—Thiotepa—hematologic cancer	0.000704	0.000802	CcSEcCtD
Bretylium—Abdominal pain—Thiotepa—hematologic cancer	0.000704	0.000802	CcSEcCtD
Bretylium—Diarrhoea—Hydroxyurea—hematologic cancer	0.0007	0.000798	CcSEcCtD
Bretylium—Nausea—Cladribine—hematologic cancer	0.000695	0.000792	CcSEcCtD
Bretylium—Vertigo—Prednisolone—hematologic cancer	0.000694	0.000792	CcSEcCtD
Bretylium—Syncope—Prednisolone—hematologic cancer	0.000693	0.00079	CcSEcCtD
Bretylium—SLC6A2—lung—hematologic cancer	0.000692	0.078	CbGeAlD
Bretylium—Mood swings—Epirubicin—hematologic cancer	0.000691	0.000788	CcSEcCtD
Bretylium—Loss of consciousness—Etoposide—hematologic cancer	0.000688	0.000785	CcSEcCtD
Bretylium—Lethargy—Doxorubicin—hematologic cancer	0.000688	0.000785	CcSEcCtD
Bretylium—Dizziness—Lenalidomide—hematologic cancer	0.000686	0.000782	CcSEcCtD
Bretylium—Dyspnoea—Mitoxantrone—hematologic cancer	0.000685	0.000781	CcSEcCtD
Bretylium—Dyspnoea—Irinotecan—hematologic cancer	0.000685	0.000781	CcSEcCtD
Bretylium—Feeling abnormal—Carmustine—hematologic cancer	0.000681	0.000777	CcSEcCtD
Bretylium—Abdominal pain—Thalidomide—hematologic cancer	0.00068	0.000776	CcSEcCtD
Bretylium—Body temperature increased—Thalidomide—hematologic cancer	0.00068	0.000776	CcSEcCtD
Bretylium—Loss of consciousness—Prednisolone—hematologic cancer	0.000679	0.000774	CcSEcCtD
Bretylium—Vomiting—Melphalan—hematologic cancer	0.000678	0.000773	CcSEcCtD
Bretylium—Hypertension—Etoposide—hematologic cancer	0.000676	0.000771	CcSEcCtD
Bretylium—Dizziness—Hydroxyurea—hematologic cancer	0.000676	0.000771	CcSEcCtD
Bretylium—Gastrointestinal pain—Carmustine—hematologic cancer	0.000676	0.000771	CcSEcCtD
Bretylium—Feeling abnormal—Alitretinoin—hematologic cancer	0.000675	0.00077	CcSEcCtD
Bretylium—Hyperhidrosis—Cisplatin—hematologic cancer	0.000675	0.000769	CcSEcCtD
Bretylium—Gastrointestinal pain—Alitretinoin—hematologic cancer	0.00067	0.000764	CcSEcCtD
Bretylium—Dyspnoea—Gemcitabine—hematologic cancer	0.000667	0.000761	CcSEcCtD
Bretylium—Hypertension—Prednisolone—hematologic cancer	0.000667	0.000761	CcSEcCtD
Bretylium—Feeling abnormal—Ifosfamide—hematologic cancer	0.000667	0.000761	CcSEcCtD
Bretylium—Nausea—Vinblastine—hematologic cancer	0.000666	0.00076	CcSEcCtD
Bretylium—Orthostatic hypotension—Epirubicin—hematologic cancer	0.000666	0.000759	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—IL1B—hematologic cancer	0.000664	0.00582	CbGpPWpGaD
Bretylium—Affect lability—Doxorubicin—hematologic cancer	0.000664	0.000757	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000664	0.00581	CbGpPWpGaD
Bretylium—Gastrointestinal pain—Ifosfamide—hematologic cancer	0.000662	0.000755	CcSEcCtD
Bretylium—Vomiting—Lenalidomide—hematologic cancer	0.000659	0.000752	CcSEcCtD
Bretylium—Bradycardia—Prednisone—hematologic cancer	0.000657	0.000749	CcSEcCtD
Bretylium—Abdominal pain—Carmustine—hematologic cancer	0.000654	0.000745	CcSEcCtD
Bretylium—Body temperature increased—Carmustine—hematologic cancer	0.000654	0.000745	CcSEcCtD
Bretylium—SLC6A2—testis—hematologic cancer	0.000653	0.0736	CbGeAlD
Bretylium—Diarrhoea—Bortezomib—hematologic cancer	0.000653	0.000745	CcSEcCtD
Bretylium—Vomiting—Hydroxyurea—hematologic cancer	0.00065	0.000741	CcSEcCtD
Bretylium—Abdominal pain—Alitretinoin—hematologic cancer	0.000647	0.000738	CcSEcCtD
Bretylium—Body temperature increased—Alitretinoin—hematologic cancer	0.000647	0.000738	CcSEcCtD
Bretylium—Gastrointestinal pain—Vincristine—hematologic cancer	0.000645	0.000736	CcSEcCtD
Bretylium—Confusional state—Etoposide—hematologic cancer	0.000645	0.000735	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000642	0.00562	CbGpPWpGaD
Bretylium—Abdominal pain—Ifosfamide—hematologic cancer	0.00064	0.00073	CcSEcCtD
Bretylium—Body temperature increased—Ifosfamide—hematologic cancer	0.00064	0.00073	CcSEcCtD
Bretylium—Mood swings—Doxorubicin—hematologic cancer	0.000639	0.000729	CcSEcCtD
Bretylium—Vertigo—Triamcinolone—hematologic cancer	0.000638	0.000728	CcSEcCtD
Bretylium—Diarrhoea—Vinorelbine—hematologic cancer	0.000638	0.000727	CcSEcCtD
Bretylium—Syncope—Triamcinolone—hematologic cancer	0.000637	0.000727	CcSEcCtD
Bretylium—Nausea—Melphalan—hematologic cancer	0.000634	0.000723	CcSEcCtD
Bretylium—Feeling abnormal—Mitoxantrone—hematologic cancer	0.000633	0.000722	CcSEcCtD
Bretylium—Feeling abnormal—Irinotecan—hematologic cancer	0.000633	0.000722	CcSEcCtD
Bretylium—Dizziness—Bortezomib—hematologic cancer	0.000631	0.00072	CcSEcCtD
Bretylium—Gastrointestinal pain—Irinotecan—hematologic cancer	0.000628	0.000717	CcSEcCtD
Bretylium—Gastrointestinal pain—Mitoxantrone—hematologic cancer	0.000628	0.000717	CcSEcCtD
Bretylium—Loss of consciousness—Triamcinolone—hematologic cancer	0.000624	0.000712	CcSEcCtD
Bretylium—Body temperature increased—Vincristine—hematologic cancer	0.000624	0.000711	CcSEcCtD
Bretylium—Abdominal pain—Vincristine—hematologic cancer	0.000624	0.000711	CcSEcCtD
Bretylium—Dyspnoea—Cisplatin—hematologic cancer	0.000622	0.000709	CcSEcCtD
Bretylium—Shock—Prednisolone—hematologic cancer	0.00062	0.000707	CcSEcCtD
Bretylium—Hyperhidrosis—Etoposide—hematologic cancer	0.000618	0.000705	CcSEcCtD
Bretylium—Feeling abnormal—Gemcitabine—hematologic cancer	0.000617	0.000704	CcSEcCtD
Bretylium—Dizziness—Vinorelbine—hematologic cancer	0.000616	0.000703	CcSEcCtD
Bretylium—Orthostatic hypotension—Doxorubicin—hematologic cancer	0.000616	0.000703	CcSEcCtD
Bretylium—Nausea—Lenalidomide—hematologic cancer	0.000616	0.000703	CcSEcCtD
Bretylium—Angina pectoris—Epirubicin—hematologic cancer	0.000614	0.0007	CcSEcCtD
Bretylium—Hypertension—Triamcinolone—hematologic cancer	0.000613	0.000699	CcSEcCtD
Bretylium—Hyperhidrosis—Prednisolone—hematologic cancer	0.00061	0.000695	CcSEcCtD
Bretylium—Diarrhoea—Thiotepa—hematologic cancer	0.000609	0.000694	CcSEcCtD
Bretylium—Body temperature increased—Irinotecan—hematologic cancer	0.000608	0.000693	CcSEcCtD
Bretylium—Abdominal pain—Mitoxantrone—hematologic cancer	0.000608	0.000693	CcSEcCtD
Bretylium—Body temperature increased—Mitoxantrone—hematologic cancer	0.000608	0.000693	CcSEcCtD
Bretylium—Abdominal pain—Irinotecan—hematologic cancer	0.000608	0.000693	CcSEcCtD
Bretylium—Nausea—Hydroxyurea—hematologic cancer	0.000607	0.000693	CcSEcCtD
Bretylium—Vomiting—Bortezomib—hematologic cancer	0.000607	0.000692	CcSEcCtD
Bretylium—Vomiting—Bleomycin—hematologic cancer	0.000602	0.000687	CcSEcCtD
Bretylium—Flushing—Prednisone—hematologic cancer	0.000599	0.000683	CcSEcCtD
Bretylium—Vomiting—Vinorelbine—hematologic cancer	0.000593	0.000676	CcSEcCtD
Bretylium—Body temperature increased—Gemcitabine—hematologic cancer	0.000592	0.000675	CcSEcCtD
Bretylium—Diarrhoea—Thalidomide—hematologic cancer	0.000589	0.000672	CcSEcCtD
Bretylium—Dizziness—Thiotepa—hematologic cancer	0.000589	0.000671	CcSEcCtD
Bretylium—Conjunctivitis—Methotrexate—hematologic cancer	0.000584	0.000666	CcSEcCtD
Bretylium—Vertigo—Betamethasone—hematologic cancer	0.000579	0.00066	CcSEcCtD
Bretylium—Vertigo—Dexamethasone—hematologic cancer	0.000579	0.00066	CcSEcCtD
Bretylium—Syncope—Dexamethasone—hematologic cancer	0.000578	0.000659	CcSEcCtD
Bretylium—Syncope—Betamethasone—hematologic cancer	0.000578	0.000659	CcSEcCtD
Bretylium—Feeling abnormal—Cisplatin—hematologic cancer	0.000575	0.000656	CcSEcCtD
Bretylium—Shock—Triamcinolone—hematologic cancer	0.00057	0.000651	CcSEcCtD
Bretylium—Dyspnoea—Etoposide—hematologic cancer	0.00057	0.00065	CcSEcCtD
Bretylium—Dizziness—Thalidomide—hematologic cancer	0.000569	0.000649	CcSEcCtD
Bretylium—Angina pectoris—Doxorubicin—hematologic cancer	0.000568	0.000648	CcSEcCtD
Bretylium—Nausea—Bortezomib—hematologic cancer	0.000567	0.000646	CcSEcCtD
Bretylium—Loss of consciousness—Dexamethasone—hematologic cancer	0.000567	0.000646	CcSEcCtD
Bretylium—Loss of consciousness—Betamethasone—hematologic cancer	0.000567	0.000646	CcSEcCtD
Bretylium—Vomiting—Thiotepa—hematologic cancer	0.000566	0.000645	CcSEcCtD
Bretylium—Diarrhoea—Carmustine—hematologic cancer	0.000566	0.000645	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000564	0.00494	CbGpPWpGaD
Bretylium—Nausea—Bleomycin—hematologic cancer	0.000563	0.000642	CcSEcCtD
Bretylium—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000561	0.000639	CcSEcCtD
Bretylium—Diarrhoea—Alitretinoin—hematologic cancer	0.00056	0.000639	CcSEcCtD
Bretylium—Hypertension—Dexamethasone—hematologic cancer	0.000557	0.000635	CcSEcCtD
Bretylium—Hypertension—Betamethasone—hematologic cancer	0.000557	0.000635	CcSEcCtD
Bretylium—Diarrhoea—Ifosfamide—hematologic cancer	0.000554	0.000632	CcSEcCtD
Bretylium—Nausea—Vinorelbine—hematologic cancer	0.000554	0.000631	CcSEcCtD
Bretylium—Body temperature increased—Cisplatin—hematologic cancer	0.000552	0.000629	CcSEcCtD
Bretylium—Vomiting—Thalidomide—hematologic cancer	0.000547	0.000624	CcSEcCtD
Bretylium—Anxiety—Betamethasone—hematologic cancer	0.000547	0.000624	CcSEcCtD
Bretylium—Anxiety—Dexamethasone—hematologic cancer	0.000547	0.000624	CcSEcCtD
Bretylium—Dizziness—Carmustine—hematologic cancer	0.000547	0.000623	CcSEcCtD
Bretylium—Conjunctivitis—Epirubicin—hematologic cancer	0.000546	0.000623	CcSEcCtD
Bretylium—Dizziness—Alitretinoin—hematologic cancer	0.000542	0.000618	CcSEcCtD
Bretylium—Diarrhoea—Vincristine—hematologic cancer	0.00054	0.000616	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000537	0.0047	CbGpPWpGaD
Bretylium—Dizziness—Ifosfamide—hematologic cancer	0.000535	0.00061	CcSEcCtD
Bretylium—ATP1A1—lymph node—hematologic cancer	0.000533	0.06	CbGeAlD
Bretylium—Nausea—Thiotepa—hematologic cancer	0.000529	0.000603	CcSEcCtD
Bretylium—Feeling abnormal—Etoposide—hematologic cancer	0.000527	0.000601	CcSEcCtD
Bretylium—Diarrhoea—Mitoxantrone—hematologic cancer	0.000526	0.0006	CcSEcCtD
Bretylium—Diarrhoea—Irinotecan—hematologic cancer	0.000526	0.0006	CcSEcCtD
Bretylium—Vomiting—Carmustine—hematologic cancer	0.000526	0.000599	CcSEcCtD
Bretylium—Gastrointestinal pain—Etoposide—hematologic cancer	0.000523	0.000596	CcSEcCtD
Bretylium—Dizziness—Vincristine—hematologic cancer	0.000522	0.000595	CcSEcCtD
Bretylium—Vomiting—Alitretinoin—hematologic cancer	0.000521	0.000594	CcSEcCtD
Bretylium—Feeling abnormal—Prednisolone—hematologic cancer	0.00052	0.000593	CcSEcCtD
Bretylium—Shock—Betamethasone—hematologic cancer	0.000518	0.00059	CcSEcCtD
Bretylium—Shock—Dexamethasone—hematologic cancer	0.000518	0.00059	CcSEcCtD
Bretylium—Dyspnoea—Triamcinolone—hematologic cancer	0.000517	0.00059	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000516	0.00451	CbGpPWpGaD
Bretylium—Vomiting—Ifosfamide—hematologic cancer	0.000515	0.000587	CcSEcCtD
Bretylium—Bradycardia—Epirubicin—hematologic cancer	0.000513	0.000586	CcSEcCtD
Bretylium—Diarrhoea—Gemcitabine—hematologic cancer	0.000512	0.000584	CcSEcCtD
Bretylium—Nausea—Thalidomide—hematologic cancer	0.000511	0.000583	CcSEcCtD
Bretylium—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000509	0.00058	CcSEcCtD
Bretylium—Hyperhidrosis—Betamethasone—hematologic cancer	0.000509	0.00058	CcSEcCtD
Bretylium—Dizziness—Irinotecan—hematologic cancer	0.000508	0.00058	CcSEcCtD
Bretylium—Abdominal pain—Etoposide—hematologic cancer	0.000505	0.000576	CcSEcCtD
Bretylium—Body temperature increased—Etoposide—hematologic cancer	0.000505	0.000576	CcSEcCtD
Bretylium—Conjunctivitis—Doxorubicin—hematologic cancer	0.000505	0.000576	CcSEcCtD
Bretylium—Vertigo—Prednisone—hematologic cancer	0.000504	0.000575	CcSEcCtD
Bretylium—Syncope—Prednisone—hematologic cancer	0.000503	0.000574	CcSEcCtD
Bretylium—Vomiting—Vincristine—hematologic cancer	0.000502	0.000572	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000499	0.00437	CbGpPWpGaD
Bretylium—Loss of consciousness—Prednisone—hematologic cancer	0.000493	0.000563	CcSEcCtD
Bretylium—Nausea—Carmustine—hematologic cancer	0.000491	0.00056	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—NQO1—hematologic cancer	0.000491	0.0043	CbGpPWpGaD
Bretylium—Vomiting—Mitoxantrone—hematologic cancer	0.000489	0.000557	CcSEcCtD
Bretylium—Vomiting—Irinotecan—hematologic cancer	0.000489	0.000557	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000487	0.00426	CbGpPWpGaD
Bretylium—Nausea—Alitretinoin—hematologic cancer	0.000486	0.000555	CcSEcCtD
Bretylium—Hypertension—Prednisone—hematologic cancer	0.000485	0.000553	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—TNF—hematologic cancer	0.000482	0.00422	CbGpPWpGaD
Bretylium—Nausea—Ifosfamide—hematologic cancer	0.000481	0.000548	CcSEcCtD
Bretylium—Feeling abnormal—Triamcinolone—hematologic cancer	0.000478	0.000545	CcSEcCtD
Bretylium—Diarrhoea—Cisplatin—hematologic cancer	0.000477	0.000544	CcSEcCtD
Bretylium—Anxiety—Prednisone—hematologic cancer	0.000476	0.000543	CcSEcCtD
Bretylium—Vomiting—Gemcitabine—hematologic cancer	0.000476	0.000543	CcSEcCtD
Bretylium—Bradycardia—Doxorubicin—hematologic cancer	0.000475	0.000542	CcSEcCtD
Bretylium—SLC6A2—lymph node—hematologic cancer	0.000473	0.0533	CbGeAlD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000472	0.00414	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000469	0.00411	CbGpPWpGaD
Bretylium—Nausea—Vincristine—hematologic cancer	0.000469	0.000535	CcSEcCtD
Bretylium—Flushing—Epirubicin—hematologic cancer	0.000468	0.000534	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—HSP90AA1—hematologic cancer	0.000461	0.00404	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000459	0.00402	CbGpPWpGaD
Bretylium—Body temperature increased—Triamcinolone—hematologic cancer	0.000458	0.000523	CcSEcCtD
Bretylium—Nausea—Mitoxantrone—hematologic cancer	0.000457	0.000521	CcSEcCtD
Bretylium—Nausea—Irinotecan—hematologic cancer	0.000457	0.000521	CcSEcCtD
Bretylium—Shock—Prednisone—hematologic cancer	0.000451	0.000514	CcSEcCtD
Bretylium—Nausea—Gemcitabine—hematologic cancer	0.000445	0.000507	CcSEcCtD
Bretylium—Vomiting—Cisplatin—hematologic cancer	0.000444	0.000506	CcSEcCtD
Bretylium—Hyperhidrosis—Prednisone—hematologic cancer	0.000443	0.000505	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000439	0.00384	CbGpPWpGaD
Bretylium—Diarrhoea—Etoposide—hematologic cancer	0.000437	0.000499	CcSEcCtD
Bretylium—Feeling abnormal—Betamethasone—hematologic cancer	0.000434	0.000494	CcSEcCtD
Bretylium—Feeling abnormal—Dexamethasone—hematologic cancer	0.000434	0.000494	CcSEcCtD
Bretylium—Flushing—Doxorubicin—hematologic cancer	0.000433	0.000494	CcSEcCtD
Bretylium—Gastrointestinal pain—Betamethasone—hematologic cancer	0.00043	0.000491	CcSEcCtD
Bretylium—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.00043	0.000491	CcSEcCtD
Bretylium—Dizziness—Etoposide—hematologic cancer	0.000423	0.000482	CcSEcCtD
Bretylium—Vertigo—Methotrexate—hematologic cancer	0.000422	0.000481	CcSEcCtD
Bretylium—Dizziness—Prednisolone—hematologic cancer	0.000417	0.000475	CcSEcCtD
Bretylium—Abdominal pain—Dexamethasone—hematologic cancer	0.000416	0.000474	CcSEcCtD
Bretylium—Body temperature increased—Dexamethasone—hematologic cancer	0.000416	0.000474	CcSEcCtD
Bretylium—Abdominal pain—Betamethasone—hematologic cancer	0.000416	0.000474	CcSEcCtD
Bretylium—Body temperature increased—Betamethasone—hematologic cancer	0.000416	0.000474	CcSEcCtD
Bretylium—Nausea—Cisplatin—hematologic cancer	0.000414	0.000473	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000414	0.00363	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.00041	0.00359	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—GSTP1—hematologic cancer	0.000409	0.00358	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000407	0.00356	CbGpPWpGaD
Bretylium—Vomiting—Etoposide—hematologic cancer	0.000406	0.000464	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000399	0.0035	CbGpPWpGaD
Bretylium—Vertigo—Epirubicin—hematologic cancer	0.000394	0.00045	CcSEcCtD
Bretylium—Syncope—Epirubicin—hematologic cancer	0.000394	0.000449	CcSEcCtD
Bretylium—Confusional state—Methotrexate—hematologic cancer	0.000386	0.00044	CcSEcCtD
Bretylium—Loss of consciousness—Epirubicin—hematologic cancer	0.000386	0.00044	CcSEcCtD
Bretylium—Dizziness—Triamcinolone—hematologic cancer	0.000383	0.000437	CcSEcCtD
Bretylium—Nausea—Etoposide—hematologic cancer	0.00038	0.000433	CcSEcCtD
Bretylium—Hypertension—Epirubicin—hematologic cancer	0.000379	0.000432	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000378	0.00331	CbGpPWpGaD
Bretylium—Feeling abnormal—Prednisone—hematologic cancer	0.000378	0.000431	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—HGF—hematologic cancer	0.000376	0.00329	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—GSTM1—hematologic cancer	0.000376	0.00329	CbGpPWpGaD
Bretylium—Gastrointestinal pain—Prednisone—hematologic cancer	0.000375	0.000427	CcSEcCtD
Bretylium—Nausea—Prednisolone—hematologic cancer	0.000375	0.000427	CcSEcCtD
Bretylium—Anxiety—Epirubicin—hematologic cancer	0.000373	0.000425	CcSEcCtD
Bretylium—Hyperhidrosis—Methotrexate—hematologic cancer	0.00037	0.000422	CcSEcCtD
Bretylium—Vomiting—Triamcinolone—hematologic cancer	0.000369	0.00042	CcSEcCtD
Bretylium—Vertigo—Doxorubicin—hematologic cancer	0.000365	0.000416	CcSEcCtD
Bretylium—Syncope—Doxorubicin—hematologic cancer	0.000364	0.000415	CcSEcCtD
Bretylium—Body temperature increased—Prednisone—hematologic cancer	0.000362	0.000413	CcSEcCtD
Bretylium—Abdominal pain—Prednisone—hematologic cancer	0.000362	0.000413	CcSEcCtD
Bretylium—Confusional state—Epirubicin—hematologic cancer	0.000361	0.000412	CcSEcCtD
Bretylium—Diarrhoea—Dexamethasone—hematologic cancer	0.00036	0.000411	CcSEcCtD
Bretylium—Diarrhoea—Betamethasone—hematologic cancer	0.00036	0.000411	CcSEcCtD
Bretylium—Loss of consciousness—Doxorubicin—hematologic cancer	0.000357	0.000407	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000356	0.00312	CbGpPWpGaD
Bretylium—Shock—Epirubicin—hematologic cancer	0.000353	0.000402	CcSEcCtD
Bretylium—Hypertension—Doxorubicin—hematologic cancer	0.000351	0.0004	CcSEcCtD
Bretylium—Dizziness—Betamethasone—hematologic cancer	0.000348	0.000397	CcSEcCtD
Bretylium—Dizziness—Dexamethasone—hematologic cancer	0.000348	0.000397	CcSEcCtD
Bretylium—Hyperhidrosis—Epirubicin—hematologic cancer	0.000346	0.000395	CcSEcCtD
Bretylium—Anxiety—Doxorubicin—hematologic cancer	0.000345	0.000393	CcSEcCtD
Bretylium—Nausea—Triamcinolone—hematologic cancer	0.000344	0.000393	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000344	0.00301	CbGpPWpGaD
Bretylium—Dyspnoea—Methotrexate—hematologic cancer	0.000341	0.000389	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000337	0.00295	CbGpPWpGaD
Bretylium—Vomiting—Betamethasone—hematologic cancer	0.000335	0.000381	CcSEcCtD
Bretylium—Vomiting—Dexamethasone—hematologic cancer	0.000335	0.000381	CcSEcCtD
Bretylium—Confusional state—Doxorubicin—hematologic cancer	0.000334	0.000381	CcSEcCtD
Bretylium—Shock—Doxorubicin—hematologic cancer	0.000326	0.000372	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—PDGFB—hematologic cancer	0.000323	0.00283	CbGpPWpGaD
Bretylium—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000321	0.000366	CcSEcCtD
Bretylium—Dyspnoea—Epirubicin—hematologic cancer	0.000319	0.000364	CcSEcCtD
Bretylium—Feeling abnormal—Methotrexate—hematologic cancer	0.000316	0.00036	CcSEcCtD
Bretylium—Diarrhoea—Prednisone—hematologic cancer	0.000313	0.000357	CcSEcCtD
Bretylium—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000313	0.000357	CcSEcCtD
Bretylium—Nausea—Betamethasone—hematologic cancer	0.000313	0.000356	CcSEcCtD
Bretylium—Nausea—Dexamethasone—hematologic cancer	0.000313	0.000356	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000308	0.0027	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000308	0.0027	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000308	0.0027	CbGpPWpGaD
Bretylium—Dizziness—Prednisone—hematologic cancer	0.000303	0.000346	CcSEcCtD
Bretylium—Abdominal pain—Methotrexate—hematologic cancer	0.000303	0.000345	CcSEcCtD
Bretylium—Body temperature increased—Methotrexate—hematologic cancer	0.000303	0.000345	CcSEcCtD
Bretylium—Dyspnoea—Doxorubicin—hematologic cancer	0.000296	0.000337	CcSEcCtD
Bretylium—Feeling abnormal—Epirubicin—hematologic cancer	0.000295	0.000337	CcSEcCtD
Bretylium—Gastrointestinal pain—Epirubicin—hematologic cancer	0.000293	0.000334	CcSEcCtD
Bretylium—Vomiting—Prednisone—hematologic cancer	0.000291	0.000332	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000287	0.00251	CbGpPWpGaD
Bretylium—Abdominal pain—Epirubicin—hematologic cancer	0.000283	0.000323	CcSEcCtD
Bretylium—Body temperature increased—Epirubicin—hematologic cancer	0.000283	0.000323	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000278	0.00243	CbGpPWpGaD
Bretylium—Feeling abnormal—Doxorubicin—hematologic cancer	0.000273	0.000312	CcSEcCtD
Bretylium—Nausea—Prednisone—hematologic cancer	0.000272	0.00031	CcSEcCtD
Bretylium—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.000271	0.000309	CcSEcCtD
Bretylium—Body temperature increased—Doxorubicin—hematologic cancer	0.000262	0.000299	CcSEcCtD
Bretylium—Abdominal pain—Doxorubicin—hematologic cancer	0.000262	0.000299	CcSEcCtD
Bretylium—Diarrhoea—Methotrexate—hematologic cancer	0.000262	0.000299	CcSEcCtD
Bretylium—Dizziness—Methotrexate—hematologic cancer	0.000253	0.000289	CcSEcCtD
Bretylium—Diarrhoea—Epirubicin—hematologic cancer	0.000245	0.00028	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000244	0.00214	CbGpPWpGaD
Bretylium—Vomiting—Methotrexate—hematologic cancer	0.000243	0.000278	CcSEcCtD
Bretylium—Dizziness—Epirubicin—hematologic cancer	0.000237	0.00027	CcSEcCtD
Bretylium—Vomiting—Epirubicin—hematologic cancer	0.000228	0.00026	CcSEcCtD
Bretylium—Nausea—Methotrexate—hematologic cancer	0.000227	0.000259	CcSEcCtD
Bretylium—Diarrhoea—Doxorubicin—hematologic cancer	0.000227	0.000259	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000223	0.00195	CbGpPWpGaD
Bretylium—Dizziness—Doxorubicin—hematologic cancer	0.000219	0.00025	CcSEcCtD
Bretylium—Nausea—Epirubicin—hematologic cancer	0.000213	0.000243	CcSEcCtD
Bretylium—Vomiting—Doxorubicin—hematologic cancer	0.000211	0.00024	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.00021	0.00184	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000204	0.00179	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000203	0.00178	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000199	0.00174	CbGpPWpGaD
Bretylium—Nausea—Doxorubicin—hematologic cancer	0.000197	0.000225	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000192	0.00168	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000179	0.00157	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000177	0.00155	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—TGFB1—hematologic cancer	0.000153	0.00134	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	0.000153	0.00134	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000149	0.0013	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000124	0.00109	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.29e-05	0.000726	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ALB—hematologic cancer	7.76e-05	0.00068	CbGpPWpGaD
